Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruiqi Huang

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 15, 2025
Concordance Between the PD-L1 Tumor Area Positivity Score and Combined Positive Score for Gastric or Esophageal Cancers Treated With TislelizumabMarkus Moehler, Harry H Yoon, Daniel-Christoph Wagner, et al.
Journal of the American Academy of Dermatology|March 4, 2019
Magnesium supplementation in the treatment of pseudoxanthoma elasticum: A randomized trialSharon Rose, Shelbi Jim On, Wayne Fuchs, et al.
Biomarker Research|March 6, 2023
Co-enrichment of CD8-positive T cells and macrophages is associated with clinical benefit of tislelizumab in solid tumorsDingwei Ye, Jayesh Desai, Jingwen Shi, et al.
ACS Nano|February 2, 2021
Immunomodulatory Layered Double Hydroxide Nanoparticles Enable Neurogenesis by Targeting Transforming Growth Factor-β Receptor 2Rongrong Zhu, Xingfei Zhu, Yanjing Zhu, et al.
Cell Reports. Medicine|December 5, 2023
Tumor-immune microenvironment and NRF2 associate with clinical efficacy of PD-1 blockade combined with chemotherapy in lung squamous cell carcinomaJianchun Duan, Yun Zhang, Ran Chen, et al.
Cellular and Molecular Gastroenterology and Hepatology|April 4, 2021
Deep Analysis of the Peripheral Immune System in IBD Reveals New Insight in Disease Subtyping and Response to Monotherapy or Combination TherapyRoman Kosoy, Seunghee Kim-Schulze, Adeeb Rahman, et al.
Gut|May 1, 2019
Infants born to mothers with IBD present with altered gut microbiome that transfers abnormalities of the adaptive immune system to germ-free miceJoana Torres, Jianzhong Hu, Akihiro Seki, et al.
Gastroenterology|September 4, 2021
Molecular Characterization of Limited Ulcerative Colitis Reveals Novel Biology and Predictors of Disease ExtensionCarmen Argmann, Minami Tokuyama, Ryan C Ungaro, et al.
Gastroenterology|November 15, 2021
Integrative Analysis of the Inflammatory Bowel Disease Serum Metabolome Improves Our Understanding of Genetic Etiology and Points to Novel Putative Therapeutic TargetsAntonio F Di'Narzo, Sander M Houten, Roman Kosoy, et al.
Cell|July 1, 2017
IFNγ-Dependent Tissue-Immune Homeostasis Is Co-opted in the Tumor MicroenvironmentChristopher J Nirschl, Mayte Suárez-Fariñas, Benjamin Izar, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 15, 2025
Concordance Between the PD-L1 Tumor Area Positivity Score and Combined Positive Score for Gastric or Esophageal Cancers Treated With TislelizumabMarkus Moehler, Harry H Yoon, Daniel-Christoph Wagner, et al.
Journal of the American Academy of Dermatology|March 4, 2019
Magnesium supplementation in the treatment of pseudoxanthoma elasticum: A randomized trialSharon Rose, Shelbi Jim On, Wayne Fuchs, et al.
Biomarker Research|March 6, 2023
Co-enrichment of CD8-positive T cells and macrophages is associated with clinical benefit of tislelizumab in solid tumorsDingwei Ye, Jayesh Desai, Jingwen Shi, et al.
ACS Nano|February 2, 2021
Immunomodulatory Layered Double Hydroxide Nanoparticles Enable Neurogenesis by Targeting Transforming Growth Factor-β Receptor 2Rongrong Zhu, Xingfei Zhu, Yanjing Zhu, et al.
Cell Reports. Medicine|December 5, 2023
Tumor-immune microenvironment and NRF2 associate with clinical efficacy of PD-1 blockade combined with chemotherapy in lung squamous cell carcinomaJianchun Duan, Yun Zhang, Ran Chen, et al.
Cellular and Molecular Gastroenterology and Hepatology|April 4, 2021
Deep Analysis of the Peripheral Immune System in IBD Reveals New Insight in Disease Subtyping and Response to Monotherapy or Combination TherapyRoman Kosoy, Seunghee Kim-Schulze, Adeeb Rahman, et al.
Gut|May 1, 2019
Infants born to mothers with IBD present with altered gut microbiome that transfers abnormalities of the adaptive immune system to germ-free miceJoana Torres, Jianzhong Hu, Akihiro Seki, et al.
Gastroenterology|September 4, 2021
Molecular Characterization of Limited Ulcerative Colitis Reveals Novel Biology and Predictors of Disease ExtensionCarmen Argmann, Minami Tokuyama, Ryan C Ungaro, et al.
Gastroenterology|November 15, 2021
Integrative Analysis of the Inflammatory Bowel Disease Serum Metabolome Improves Our Understanding of Genetic Etiology and Points to Novel Putative Therapeutic TargetsAntonio F Di'Narzo, Sander M Houten, Roman Kosoy, et al.
Cell|July 1, 2017
IFNγ-Dependent Tissue-Immune Homeostasis Is Co-opted in the Tumor MicroenvironmentChristopher J Nirschl, Mayte Suárez-Fariñas, Benjamin Izar, et al.
Pageof 9